Printer Friendly

MICROPROBE AND OLYMPUS TO DEVELOP DNA PROBE-BASED DIAGNOSTIC SYSTEM

            MICROPROBE AND OLYMPUS TO DEVELOP DNA
               PROBE-BASED DIAGNOSTIC SYSTEM
    GARDEN GROVE, Calif., Nov. 13 /PRNewswire/ -- MicroProbe Corp., based here, today announced that it has signed an agreement with Olympus Optical Co. Ltd. to jointly develop a diagnostic system based on MicroProbe's DNA probe technology.
    Under the agreement, both companies will contribute proprietary technology toward the development of an automated diagnostic system for the rapid identification of certain disease pathogens.  Financial details were not disclosed.
    DNA probes are comprised of synthetic DNA subunits called oligonucleotides that are designed to bind to a single strand of target DNA unique to a specific organism.  DNA probes are ideal diagnostic reagents because of their high hybridization specificity, low cost, precisely known sequence and chemical structure.
    Based in Tokyo, Olympus Optical Co., Ltd. was founded in 1919 and maintains more than 20 subsidiaries and representative offices around the world.  It encompasses business lines in a wide variety of products based on optical as well as electronic technology.  Olympus commands a lead position in many areas of biomedical instrumentation including endoscopes, microscopes and clinical chemistry analyzers.
    Founded in 1985, MicroProbe Corp. is a biomedical company focused on delivering DNA probe technologies for practical use in medicine. The privately held firm is commercializing synthetic DNA probes for the rapid identification of pathogens and the treatment of certain infectious diseases and cancers.  The company operates three divisions -- a diagnostics and a therapeutics division located together in Bothell, Wash., and an OEM systems division operating as Source Scientific Systems in Garden Grove.
    -0-                     11/13/91
    /CONTACT:  John L. Bishop of MicroProbe, 714-894-7184/ CO:  MicroProbe; Olympus Optical Co. ST:  California IN:  MTC SU:  PDT JL -- SJ004 -- 4000 11/13/91 13:42 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 13, 1991
Words:284
Previous Article:TRANSMEDIA NETWORK ANNOUNCES INFORMATION ON ITS FORTHCOMING CALIFORNIA FRANCHISEE
Next Article:NATION'S FIRST MASS-PRODUCED NATURAL GAS-POWERED TRUCK UNVEILED Gas Company To Add First 100 GMC Sierra Pickups To Its Fleet
Topics:


Related Articles
MICROPROBE RECEIVES FDA CLEARANCE TO MARKET FIRST MICROBIAL IDENTIFICATION SYSTEM FOR VAGINITIS
MICROPROBE RECEIVES $8 MILLION TO EXPAND PRODUCT DEVELOPMENT AND MARKETING
MICROPROBE RESPONDS TO GEN-PROBE'S PATENT INFRINGEMENT SUIT
HYSEQ TO LICENSE HIGH-SPEED GENE-SEQUENCING TECHNOLOGY FOR DIAGNOSTIC APPLICATIONS; NEW DEVELOPMENTS NOW AVAILABLE
MICROPROBE AGREES GEN-PROBE PATENTS VALID
MICROPROBE SIGNS BINDING AGREEMENT TO SELL DIAGNOSTICS BUSINESS
Aprogenex Announces Collaboration with AmCell
Sabratek's CMS Healthcare Subsidiary Signs Contract with Olympus Managed Health Care.
BioGenex Awarded U.S. Patent on the Synthesis of Branched Oligomers For Nucleic Acid Labeling and Amplification.
Applied Imaging Announces Exclusive Distribution Deal With Leading Instrument Supplier in Italy.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters